F069 Pediatric Dermatology M&M
DESCRIPTION
Morbidity and mortality sessions provide caregivers with a structured forum to review adverse outcomes in medicine. Our session will be a case-based review of complications encountered while caring for children in both inpatient and outpatient settings. We will review cases that provide teaching points to improve care by decreasing errors in communication and practice. Cases will also solidify the difference between adverse events that can be avoided and those that are inherent risks of illness. This forum is a blameless environment to help all of us learn.
LEARNING OBJECTIVES
Identify gaps in communication that lead to error.
Differentiate adverse events that are risks of therapy or disease and those that result from error.
Discuss strategies for handling and coping with adverse events.
SCHEDULE
3:30 PM
Pediatric Dermatology M&M
DIRECTOR
Nicole Noelani Harter, MD, FAAD
SPEAKERS
Colleen Cotton, MD, FAAD
Dawn Eichenfield, PhD, MD, FAAD
Deepti Gupta, MD
Nikita Lakdawala, MD, FAAD
Amanda Theresa Moon, MD, FAAD
DISCLOSURES
Colleen Cotton, MD, FAAD
Amgen – Investigator(Grants/Research Funding); CorEvitas – Investigator(Grants/Research Funding); Dermatology Foundation – Investigator(Grants/Research Funding); HS Foundation – Board of Directors(No Compensation Received), Investigator(Grants/Research Funding); Inner Archways LLC – Advisory Board(Other Financial Benefit); MoonLake Immunotherapeutics – Investigator(Grants/Research Funding); Novartis – Advisory Board(Honoraria); Pfizer Inc. – Consultant (1099 relationship)(No Compensation Received), Investigator(Grants/Research Funding); Pierre Fabre – Consultant(Honoraria); UCB – Investigator(Grants/Research Funding);
Dawn Eichenfield, PhD, MD, FAAD
Amryt Pharma/ Chiesi Farmaceutici – Consultant(Fees); Apogee Therapeutics – Consultant (1099 relationship)(Fees); Arcutis, Inc. – Consultant (1099 relationship)(Fees); Beiersdorf, Inc. – Consultant (1099 relationship)(Fees), Speaker(Honoraria); Eli Lilly and Company – Advisory Board(Fees), Investigator(Grants/Research Funding); Galderma Laboratories, LP – Speaker(Honoraria); Incyte Corporation – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Janssen Pharmaceuticals, Inc – Investigator(Grants/Research Funding); NobelPharma – Advisory Board(Fees), Speaker(Honoraria); Ortho Dermatologics – Advisory Board(Fees); Palvella Therapeutics – Consultant (1099 relationship)(Fees); Pelthos Therapeutics – Advisory Board(Fees); Sanofi/Regeneron – Speaker(Honoraria); Verrica Pharmaceuticals Inc – Advisory Board(Fees), Speaker(Honoraria);
Deepti Gupta, MD
No financial relationships exist with ineligible companies.
Nicole Noelani Harter, MD, FAAD
Regeneron – Speaker/Faculty Education(Honoraria); Sanofi – Speaker/Faculty Education(Honoraria);
Nikita Lakdawala, MD, FAAD
No financial relationships exist with ineligible companies.
Amanda Theresa Moon, MD, FAAD
No financial relationships exist with ineligible companies.